MarketPulse

financial diversification

2 articles
The Motley FoolThe Motley Fool··Seena Hassouna

Immunome Insider Sale Masks Real Story: FDA Filing Looms for Varegacestat

Immunome's Chief Scientific Officer trimmed his stake by 30%, but the real catalyst is varegacestat's planned Q2 2026 FDA submission following positive Phase 3 trial results.
IMNMPhase 3 trialNDA submission
The Motley FoolThe Motley Fool··Seena Hassouna

Trupanion CFO Completes Systematic Stock Divestment With Final Share Sale

Trupanion CFO completed nine-month systematic stock divestment of 19,859 shares via pre-planned 10b5-1 trading arrangement, signaling financial diversification rather than company concerns.
TRUPinsider trading10b5-1 trading plan
financial diversification News | MarketPulse